DE2602891A1 - Neue 13-aethinyl-steroide und verfahren zu ihrer herstellung - Google Patents

Neue 13-aethinyl-steroide und verfahren zu ihrer herstellung

Info

Publication number
DE2602891A1
DE2602891A1 DE19762602891 DE2602891A DE2602891A1 DE 2602891 A1 DE2602891 A1 DE 2602891A1 DE 19762602891 DE19762602891 DE 19762602891 DE 2602891 A DE2602891 A DE 2602891A DE 2602891 A1 DE2602891 A1 DE 2602891A1
Authority
DE
Germany
Prior art keywords
compound
group
hydrogen atom
general formula
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762602891
Other languages
German (de)
English (en)
Inventor
Michel Dr Biollaz
Jaroslav Dr Kalvoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2602891A1 publication Critical patent/DE2602891A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
DE19762602891 1975-01-30 1976-01-27 Neue 13-aethinyl-steroide und verfahren zu ihrer herstellung Pending DE2602891A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH112375A CH606101A5 (cg-RX-API-DMAC10.html) 1975-01-30 1975-01-30

Publications (1)

Publication Number Publication Date
DE2602891A1 true DE2602891A1 (de) 1976-08-05

Family

ID=4203021

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762602891 Pending DE2602891A1 (de) 1975-01-30 1976-01-27 Neue 13-aethinyl-steroide und verfahren zu ihrer herstellung

Country Status (15)

Country Link
US (1) US4052421A (cg-RX-API-DMAC10.html)
JP (1) JPS51100068A (cg-RX-API-DMAC10.html)
AU (1) AU503505B2 (cg-RX-API-DMAC10.html)
BE (1) BE838019A (cg-RX-API-DMAC10.html)
CA (1) CA1065302A (cg-RX-API-DMAC10.html)
CH (1) CH606101A5 (cg-RX-API-DMAC10.html)
DE (1) DE2602891A1 (cg-RX-API-DMAC10.html)
DK (1) DK138698B (cg-RX-API-DMAC10.html)
ES (1) ES444689A1 (cg-RX-API-DMAC10.html)
FR (1) FR2299034A1 (cg-RX-API-DMAC10.html)
GB (1) GB1514621A (cg-RX-API-DMAC10.html)
IE (1) IE42468B1 (cg-RX-API-DMAC10.html)
IL (1) IL48937A (cg-RX-API-DMAC10.html)
SE (1) SE7514455L (cg-RX-API-DMAC10.html)
ZA (1) ZA76506B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones
ATE527192T1 (de) 2009-03-02 2011-10-15 Sala Jaime Marti Rotationsförderer für leichte gegenstände

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
US3267005A (en) * 1963-10-23 1966-08-16 American Home Prod Resolution of racemic delta4-3-ketosteroids
US3798215A (en) * 1968-11-25 1974-03-19 Sandoz Ag Propadienyl-substituted carbinols

Also Published As

Publication number Publication date
AU1064476A (en) 1977-08-04
IE42468B1 (en) 1980-08-13
DK563775A (cg-RX-API-DMAC10.html) 1976-07-31
ES444689A1 (es) 1977-05-16
IL48937A (en) 1979-07-25
CA1065302A (en) 1979-10-30
SE7514455L (sv) 1976-08-02
FR2299034A1 (fr) 1976-08-27
CH606101A5 (cg-RX-API-DMAC10.html) 1978-10-13
ZA76506B (en) 1977-01-26
DK138698C (cg-RX-API-DMAC10.html) 1979-03-19
BE838019A (fr) 1976-07-29
US4052421A (en) 1977-10-04
FR2299034B1 (cg-RX-API-DMAC10.html) 1979-09-21
JPS51100068A (cg-RX-API-DMAC10.html) 1976-09-03
GB1514621A (en) 1978-06-14
IL48937A0 (en) 1976-03-31
DK138698B (da) 1978-10-16
IE42468L (en) 1976-07-30
AU503505B2 (en) 1979-09-06

Similar Documents

Publication Publication Date Title
DE2361120C2 (de) 11,11-Alkylidensteroide der Östran- und Norpregnan-Reihe, Verfahren zu ihrer Herstellung und deren Verwendung
DE2035738A1 (de) Neue Androstandenvate und Verfahren zu ihrer Herstellung
CH646984A5 (de) 10-alkinyl-steroide.
DE2631915A1 (de) 16-dehydroandrostan-derivate
DE1443682B2 (de) 7 alpha, 17 alpha-dimethyl-oestradiol und sein 3-methylaether, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3872938T2 (de) 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol-derivate und verwandte verbindungen als c17-20 lyase-inhibitoren.
DE1518994A1 (de) Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden
DE1568308B2 (de) Verfahren zur herstellung von delta hoch 4,9,11-trienen der 19-nor- androstanreihe, 17-oxygenierte 3-oxo- 7 alpha-methyl-delta hoch 4,9,11-19 nor- androstatriene und diese enthaltende pharmazeutische praeparate sowie 3-oxo-7 alpha -methyl-delta hoch 5 (10), 9 (11) -19-nor- androstadiene
DE1920145A1 (de) Neue Steroide und deren Herstellung
EP0005758B1 (de) Verfahren zum Aufbau der Hydroxyacetyl-Seitenkette von Steroiden des Pregnan-Typs, neue 21-Hydroxy-20-oxo-17alpha-pregnan-Verbindungen und pharmazeutische Präparate enthaltend dieselben
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2533496A1 (de) Neue difluorsteroide und verfahren zu ihrer herstellung
DE1643028C3 (de) Neue 1,2 alpha -Methylensteroide, Verfahren zu ihrer Herstellung, sowie diese enthaltende Mittel
DE1668205C3 (de) 16 alpha-Alkylthio-9beta, lOalpha-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2632550A1 (de) Neue fluorsteroide und verfahren zu ihrer herstellung
DE3315324A1 (de) Verfahren zur herstellung von 17(alpha)-(br oder j)-ethinyl-17ss-or-steroiden
DE3005374A1 (de) 3-desoxy-delta hoch 15 -steroide, verfahren zu ihrer herstellung sowie diese enthaltende pharmazeutische praeparate
DE4018828C2 (de) Verfahren zur Herstellung C7-alpha-substituierter 8alpha- und 8ß-Estra-1,3,5(10)-triene und C8-alpha-substituierter Estra-1,3,5(10)-triene sowie neue Zwischenprodukte für dieses Verfahren
DE2004313A1 (de) 3-Desoxo-19-nor-steroidverbindungen und Verfahren zu ihrer Herstellung
DE1568306C3 (de) Delta hoch 4,9 -7 alpha-Methyl-19nor-androstadiene, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE1493114C3 (cg-RX-API-DMAC10.html)
DE1493108C (de) Steroidverbindungen
DE1813728C3 (de) 3-Oxo-A-nor-B-homo-östr-5(10)-ene und ein Verfahren zu deren Herstellung
DE2018055A1 (de) Neue Steroide und Verfahren zu ihrer Herstellung
CH606093A5 (en) 18,18-Difluoro steroids prepn. with hormonal activity

Legal Events

Date Code Title Description
OHN Withdrawal